(R)-lipoic acid multiple interactions ISO RGD:732523 6480464 Thioctic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of TGFB1I1 mRNA] CTD PMID:23608068 1,2-dimethylhydrazine increases expression ISO RGD:732523 6480464 1, 2-Dimethylhydrazine results in increased expression of TGFB1I1 mRNA CTD PMID:22206623 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of TGFB1I1 mRNA, Estradiol inhibits the reaction [ESR1 protein binds to TGFB1I1 protein] CTD PMID:29389661 , PMID:30165855 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one multiple interactions EXP 6480464 [Metribolone binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to TGFB1I1 protein modified form] CTD PMID:28751236 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:732523 6480464 Tetrachlorodibenzodioxin results in decreased expression of TGFB1I1 mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732523 6480464 Tetrachlorodibenzodioxin affects the expression of TGFB1I1 mRNA CTD PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of TGFB1I1 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of TGFB1I1 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:620173 6480464 2 more ... CTD PMID:32109520 2-methylcholine affects expression EXP 6480464 beta-methylcholine affects the expression of TGFB1I1 mRNA CTD PMID:21179406 3-phenylprop-2-enal decreases expression EXP 6480464 cinnamic aldehyde results in decreased expression of TGFB1I1 mRNA CTD PMID:17178418 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bis4-hydroxyphenylsulfone binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to TGFB1I1 protein modified form], bis4-hydroxyphenylsulfone inhibits the reaction [ESR1 protein binds to TGFB1I1 protein] CTD PMID:28751236 , PMID:29389661 4,4'-sulfonyldiphenol increases expression ISO RGD:732523 6480464 bis4-hydroxyphenylsulfone results in increased expression of TGFB1I1 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression ISO RGD:732523 6480464 Fenretinide results in increased expression of TGFB1I1 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of TGFB1I1 mRNA CTD PMID:19194470 8-Br-cAMP decreases expression EXP 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of TGFB1I1 mRNA CTD PMID:22079614 9-cis-retinoic acid increases expression EXP 6480464 Alitretinoin results in increased expression of TGFB1I1 mRNA CTD PMID:15982314 acrolein multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TGFB1I1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TGFB1I1 mRNA CTD PMID:32699268 aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of TGFB1I1 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of TGFB1I1 mRNA CTD PMID:21632981 all-trans-4-oxoretinoic acid increases expression EXP 6480464 4-oxoretinoic acid results in increased expression of TGFB1I1 mRNA CTD PMID:15982314 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin metabolite results in increased expression of TGFB1I1 mRNA, Tretinoin results in increased expression of TGFB1I1 mRNA CTD PMID:15982314 all-trans-retinoic acid increases expression ISO RGD:732523 6480464 Tretinoin results in increased expression of TGFB1I1 mRNA CTD PMID:16604517 alpha-pinene multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TGFB1I1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of TGFB1I1 mRNA CTD PMID:32699268 ammonium chloride affects expression ISO RGD:620173 6480464 Ammonium Chloride affects the expression of TGFB1I1 mRNA CTD PMID:16483693 Aroclor 1254 increases expression ISO RGD:732523 6480464 Chlorodiphenyl 54% Chlorine results in increased expression of TGFB1I1 mRNA CTD PMID:23650126 azathioprine increases expression EXP 6480464 Azathioprine results in increased expression of TGFB1I1 mRNA CTD PMID:22623647 benzo[a]pyrene increases expression ISO RGD:732523 6480464 Benzoapyrene results in increased expression of TGFB1I1 mRNA CTD PMID:22228805 , PMID:32417428 benzo[a]pyrene increases methylation EXP 6480464 Benzoapyrene results in increased methylation of TGFB1I1 3' UTR CTD PMID:27901495 benzo[a]pyrene decreases methylation EXP 6480464 Benzoapyrene results in decreased methylation of TGFB1I1 promoter CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of TGFB1I1 mRNA CTD PMID:20106945 more ... benzo[a]pyrene affects expression ISO RGD:732523 6480464 Benzoapyrene affects the expression of TGFB1I1 mRNA CTD PMID:22342234 bisphenol A increases expression ISO RGD:620173 6480464 bisphenol A results in increased expression of TGFB1I1 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:620173 6480464 bisphenol A results in decreased expression of TGFB1I1 mRNA CTD PMID:30816183 bisphenol A increases expression ISO RGD:732523 6480464 bisphenol A results in increased expression of TGFB1I1 mRNA CTD PMID:30951980 bisphenol A multiple interactions EXP 6480464 [bisphenol A binds to and affects the folding of AR protein] promotes the reaction [AR protein modified form binds to TGFB1I1 protein modified form], bisphenol A inhibits the reaction [ESR1 protein binds to TGFB1I1 protein] CTD PMID:28751236 , PMID:29389661 bisphenol F increases expression ISO RGD:732523 6480464 bisphenol F results in increased expression of TGFB1I1 mRNA CTD PMID:30951980 bleomycin A2 decreases expression ISO RGD:620173 6480464 Bleomycin results in decreased expression of TGFB1I1 protein CTD PMID:25933445 buta-1,3-diene decreases expression ISO RGD:732523 6480464 1, 3-butadiene results in decreased expression of TGFB1I1 mRNA CTD PMID:29038090 butanal increases expression EXP 6480464 butyraldehyde results in increased expression of TGFB1I1 mRNA CTD PMID:26079696 C60 fullerene increases expression ISO RGD:620173 6480464 fullerene C60 results in increased expression of TGFB1I1 mRNA CTD PMID:19167457 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of TGFB1I1 protein CTD PMID:24527689 choline multiple interactions ISO RGD:732523 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TGFB1I1 mRNA CTD PMID:20938992 cisplatin decreases expression ISO RGD:620173 6480464 Cisplatin results in decreased expression of TGFB1I1 mRNA CTD PMID:22023808 cisplatin multiple interactions EXP 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of TGFB1I1 mRNA CTD PMID:27392435 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of TGFB1I1 mRNA CTD PMID:27392435 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of TGFB1I1 mRNA CTD PMID:19320972 copper atom increases expression ISO RGD:620173 6480464 Copper deficiency results in increased expression of TGFB1I1 mRNA CTD PMID:26033743 copper(0) increases expression ISO RGD:620173 6480464 Copper deficiency results in increased expression of TGFB1I1 mRNA CTD PMID:26033743 copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of TGFB1I1 mRNA CTD PMID:19549813 crocidolite asbestos affects expression EXP 6480464 Asbestos, Crocidolite affects the expression of TGFB1I1 mRNA CTD PMID:17331233 crocidolite asbestos decreases expression ISO RGD:732523 6480464 Asbestos, Crocidolite results in decreased expression of TGFB1I1 mRNA CTD PMID:29279043 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of TGFB1I1 mRNA CTD PMID:20106945 more ... cyproterone acetate multiple interactions EXP 6480464 [Cyproterone Acetate binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to TGFB1I1 protein modified form] CTD PMID:28751236 daidzein multiple interactions EXP 6480464 daidzein promotes the reaction [TGFB1I1 protein results in increased activity of AR protein] CTD PMID:17252558 dibutyl phthalate increases expression ISO RGD:620173 6480464 Dibutyl Phthalate results in increased expression of TGFB1I1 mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO RGD:732523 6480464 Dibutyl Phthalate results in increased expression of TGFB1I1 mRNA CTD PMID:21266533 diuron increases expression ISO RGD:620173 6480464 Diuron results in increased expression of TGFB1I1 mRNA CTD PMID:21551480 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 doxorubicin affects response to substance EXP 6480464 TGFB1I1 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of TGFB1I1 mRNA CTD PMID:29803840 endosulfan decreases expression ISO RGD:620173 6480464 Endosulfan results in decreased expression of TGFB1I1 mRNA CTD PMID:29391264 entinostat increases expression EXP 6480464 entinostat results in increased expression of TGFB1I1 mRNA CTD PMID:26272509 , PMID:27188386 entinostat multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of TGFB1I1 mRNA CTD PMID:27188386 flavonoids decreases expression ISO RGD:620173 6480464 Flavonoids results in decreased expression of TGFB1I1 mRNA CTD PMID:18035473 folic acid multiple interactions ISO RGD:732523 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TGFB1I1 mRNA CTD PMID:20938992 folic acid decreases expression ISO RGD:732523 6480464 Folic Acid results in decreased expression of TGFB1I1 mRNA CTD PMID:25629700 hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of TGFB1I1 mRNA CTD PMID:23410634 isotretinoin increases expression EXP 6480464 Isotretinoin results in increased expression of TGFB1I1 mRNA CTD PMID:15982314 L-methionine multiple interactions ISO RGD:732523 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TGFB1I1 mRNA CTD PMID:20938992 lipoic acid multiple interactions ISO RGD:732523 6480464 Thioctic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of TGFB1I1 mRNA] CTD PMID:23608068 menadione affects expression EXP 6480464 Vitamin K 3 affects the expression of TGFB1I1 mRNA CTD PMID:23410634 mercury dibromide multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of TGFB1I1 mRNA CTD PMID:27188386 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Ethylmercury Compounds results in increased expression of TGFB1I1 mRNA] CTD PMID:27511942 nickel subsulfide decreases expression ISO RGD:620173 6480464 nickel subsulfide results in decreased expression of TGFB1I1 mRNA CTD PMID:24952340 nitrofen decreases expression ISO RGD:620173 6480464 nitrofen results in decreased expression of TGFB1I1 mRNA CTD PMID:20638522 ozone multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of TGFB1I1 mRNA more ... CTD PMID:32699268 panobinostat multiple interactions EXP 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of TGFB1I1 mRNA CTD PMID:27188386 panobinostat increases expression EXP 6480464 panobinostat results in increased expression of TGFB1I1 mRNA CTD PMID:26272509 paracetamol affects expression ISO RGD:732523 6480464 Acetaminophen affects the expression of TGFB1I1 mRNA CTD PMID:17562736 phenylephrine increases expression ISO RGD:620173 6480464 Phenylephrine results in increased expression of TGFB1I1 protein CTD PMID:19540241 phenylephrine multiple interactions ISO RGD:620173 6480464 [Phenylephrine results in increased phosphorylation of MAPK1 protein] which affects the expression of TGFB1I1 protein more ... CTD PMID:19540241 phenylmercury acetate increases expression EXP 6480464 Phenylmercuric Acetate results in increased expression of TGFB1I1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of TGFB1I1 mRNA CTD PMID:27188386 potassium dichromate multiple interactions ISO RGD:732523 6480464 Thioctic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of TGFB1I1 mRNA] CTD PMID:23608068 potassium dichromate decreases expression ISO RGD:732523 6480464 Potassium Dichromate results in decreased expression of TGFB1I1 mRNA CTD PMID:23608068 quercetin increases expression EXP 6480464 Quercetin results in increased expression of TGFB1I1 mRNA CTD PMID:21632981 rotenone increases expression EXP 6480464 Rotenone results in increased expression of TGFB1I1 mRNA CTD PMID:29955902 rotenone decreases expression ISO RGD:620173 6480464 Rotenone results in decreased expression of TGFB1I1 mRNA CTD PMID:28374803 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 sodium fluoride decreases expression ISO RGD:732523 6480464 Sodium Fluoride results in decreased expression of TGFB1I1 protein CTD PMID:28918527 tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of TGFB1I1 mRNA CTD PMID:15336504 tert-butyl hydroperoxide affects expression EXP 6480464 tert-Butylhydroperoxide affects the expression of TGFB1I1 mRNA CTD PMID:23410634 testosterone decreases expression EXP 6480464 Testosterone results in decreased expression of TGFB1I1 mRNA CTD PMID:21880219 trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of TGFB1I1 mRNA CTD PMID:24935251 triclosan decreases expression EXP 6480464 Triclosan results in decreased expression of TGFB1I1 mRNA CTD PMID:30510588 tunicamycin increases expression ISO RGD:732523 6480464 Tunicamycin results in increased expression of TGFB1I1 mRNA CTD PMID:17127020 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of TGFB1I1 mRNA CTD PMID:29154799 valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of TGFB1I1 mRNA CTD PMID:27188386 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of TGFB1I1 mRNA CTD PMID:26272509 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of TGFB1I1 mRNA CTD PMID:25979313 vancomycin decreases expression ISO RGD:732523 6480464 Vancomycin results in decreased expression of TGFB1I1 mRNA CTD PMID:18930951 vanillin decreases expression EXP 6480464 vanillin results in decreased expression of TGFB1I1 mRNA CTD PMID:17178418 vinclozolin decreases expression ISO RGD:620173 6480464 vinclozolin results in decreased expression of TGFB1I1 mRNA CTD PMID:23034163 zoledronic acid increases expression EXP 6480464 zoledronic acid results in increased expression of TGFB1I1 protein CTD PMID:28871336